Product Code: GVR-1-68038-916-6
North America Dietary Supplements Market Growth & Trends:
The North America dietary supplements market is anticipated to reach USD 86.65 billion by 2030 and is projected to expand at a CAGR of 5.8% during the forecast period, according to a new report by Grand View Research, Inc. The market for dietary supplements is growing due to growing awareness regarding the role of dietary preference in human health and the increasing consumer focus on overall well-being.
Large number of consumers have been focusing on embracing lifestyles and dietary preferences that assist them in leading healthy lifestyles. This has significant increased the demand for dietary supplements in the regional industry. Development of applications specific dietary supplements by the key market participants also contribute to rising adoption. Increasing availability of information regarding benefits associated with consumption of dietary supplements and ease of accessibility facilitated by the effective distribution strategies implemented by the major market participants are likely to develop noteworthy growth for this market in coming years.
Product innovation, new product developments, and the increasing adoption of novel technologies in marketing and supply chain management have facilitated this market's growth. The multi-channel distribution strategies embraced by the major companies add lucrative growth opportunities to this market. Companies are adopting new technologies and personalized strategies to address changing consumer requirements. This includes fulfilling nutritional needs through cost-effective packaging.
The retail channel remains critical to the expansion of the market, with offline outlets such as supermarkets dominating and accounting for more than half of regional sales. However, online sales are growing rapidly due to convenience and cost-effectiveness. The growing elderly demographic and increasing prevalence of chronic disorders such as obesity augment the demand for dietary supplements. Collaboration with online retailers expands strategic partnerships, while technological innovations such as microencapsulation add value while enhancing competitiveness.
North America Dietary Supplements Market Report Highlights:
- Vitamins dominated the ingredients segment with more than 25.0% share in 2024 owing to the rising demand for vitamin supplements and increasing incidence of vitamin deficiencies worldwide.
- Liquids segment is expected to experience the fastest CAGR over forecast period.
- Energy & weight management accounted for the largest revenue share of North America dietary supplements market.
- Prenatal health segment is anticipated to experience fastest growth from 2025 to 2030.
- The offline distribution segment dominated the North America dietary supplements market in 2024.
- The increasing popularity of e-commerce, the adaptation of new technologies, and the cost-effectiveness of retail channels are contributing to the growth of the market.
- In February 2024, Herbalife launched the GLP-1 Nutrition Companion product line, combining food and supplement offerings. Available in the U.S. and Puerto Rico, the product line includes Classic and Vegan options that provide essential protein, fiber, vitamins, and minerals to address potential nutritional deficiencies caused by these medications.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. North America Dietary Supplements Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Industry Challenges
- 3.3.4. Industry Opportunities
- 3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Consumer Behavior Analysis
- 4.1. Demographic Analysis
- 4.2. Consumer Trends & Preferences
- 4.3. Factors Influencing Buying Decisions
- 4.4. Consumer Product Adoption Trends
- 4.5. Observations & Recommendations
Chapter 5. North America Dietary Supplements Market: Ingredient Estimates & Trend Analysis
- 5.1. North America Dietary Supplements Market Ingredient: Key Takeaways
- 5.2. Ingredient Movement Analysis & Market Share, 2024 & 2030
- 5.3. North America Dietary Supplements Market Estimates & Forecast, By Ingredient, 2018 to 2030 (USD Million)
- 5.3.1. Vitamins
- 5.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.2. Botanicals
- 5.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.3. Minerals
- 5.3.3.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.4. Proteins & Amino Acids
- 5.3.4.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.5. Fibers & Specialty Carbohydrates
- 5.3.5.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.6. Omega Fatty Acids
- 5.3.6.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.7. Probiotics
- 5.3.7.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.8. Pre & Postbiotics
- 5.3.8.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 5.3.9. Others
- 5.3.9.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 6. North America Dietary Supplements Market: Form Estimates & Trend Analysis
- 6.1. North America Dietary Supplements Market Form: Key Takeaways
- 6.2. Form Movement Analysis & Market Share, 2024 & 2030
- 6.3. North America Dietary Supplements Market Estimates & Forecast, By Form, 2018 to 2030 (USD Million)
- 6.3.1. Tablets
- 6.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.2. Capsules
- 6.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.3. Soft Gels
- 6.3.3.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.4. Powders
- 6.3.4.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.5. Gummies
- 6.3.5.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.6. Liquids
- 6.3.6.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 6.3.7. Others
- 6.3.7.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 7. North America Dietary Supplements Market: Application Estimates & Trend Analysis
- 7.1. North America Dietary Supplements Market Application: Key Takeaways
- 7.2. Application Movement Analysis & Market Share, 2024 & 2030
- 7.3. North America Dietary Supplements Market Estimates & Forecast, By Application, 2018 to 2030 (USD Million)
- 7.3.1. Energy & Weight Management
- 7.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.2. General Health
- 7.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.3. Bone & Joint Health
- 7.3.3.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.4. Gastrointestinal Health
- 7.3.4.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.5. Immunity
- 7.3.5.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.6. Cardiac Health
- 7.3.6.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.7. Diabetes
- 7.3.7.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.8. Anti-cancer
- 7.3.8.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.9. Lungs Detox/Cleanse
- 7.3.9.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.10. Skin/Hair/Nails
- 7.3.10.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.11. Sexual Health
- 7.3.11.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.12. Brain/Mental Health
- 7.3.12.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.13. Insomnia
- 7.3.13.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.14. Menopause
- 7.3.14.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.15. Anti-aging
- 7.3.15.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.16. Prenatal Health
- 7.3.16.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 7.3.17. Others
- 7.3.17.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 8. North America Dietary Supplements Market: End Use Estimates & Trend Analysis
- 8.1. North America Dietary Supplements Market End Use: Key Takeaways
- 8.2. End Use Movement Analysis & Market Share, 2024 & 2030
- 8.3. North America Dietary Supplements Market Estimates & Forecast, By End Use, 2018 to 2030 (USD Million)
- 8.3.1. Adults
- 8.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 8.3.2. Geriatric
- 8.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 8.3.3. Pregnant Woman
- 8.3.3.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 8.3.4. Children
- 8.3.4.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 8.3.5. Infants
- 8.3.5.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 9. North America Dietary Supplements Market: Type Estimates & Trend Analysis
- 9.1. North America Dietary Supplements Market Type: Key Takeaways
- 9.2. Type Movement Analysis & Market Share, 2024 & 2030
- 9.3. North America Dietary Supplements Market Estimates & Forecast, By Type, 2018 to 2030 (USD Million)
- 9.3.1. OTC
- 9.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 9.3.2. Prescribed
- 9.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 10. North America Dietary Supplements Market: Distribution Channel Estimates & Trend Analysis
- 10.1. North America Dietary Supplements Market Distribution Channel: Key Takeaways
- 10.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 10.3. North America Dietary Supplements Market Estimates & Forecast, By Distribution Channel, 2018 to 2030 (USD Million)
- 10.3.1. Offline
- 10.3.1.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.1.2. Hypermarkets/Supermarkets
- 10.3.1.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.1.3. Pharmacies
- 10.3.1.3.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.1.4. Specialty Stores
- 10.3.1.4.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.1.5. Practioner
- 10.3.1.5.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.1.6. Others (Direct to Consumer, MLM)
- 10.3.1.6.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
- 10.3.2. Online
- 10.3.2.1. Market Estimates & Forecasts, 2018 to 2030 (USD Million)
Chapter 11. North America Dietary Supplements Market: Regional Estimates & Trend Analysis
- 11.1. North America Dietary Supplements Market: Regional Outlook
- 11.2. Regional Marketplaces: Key Takeaways
- 11.3. North America Dietary Supplements Market Estimates & Forecast, By Country, 2018 to 2030 (USD Million)
- 11.4. U.S.
- 11.4.1. Key Country Dynamics
- 11.4.2. U.S. Dietary Supplements market estimates & forecast, 2018 - 2030 (USD Million)
- 11.5. Canada
- 11.5.1. Key Country Dynamics
- 11.5.2. Canada Dietary Supplements market estimates & forecast, 2018 - 2030 (USD Million)
- 11.6. Mexico
- 11.6.1. Key Country Dynamics
- 11.6.2. Mexico Dietary Supplements market estimates & forecast, 2018 - 2030 (USD Million)
Chapter 12. North America Dietary Supplements Market - Competitive Landscape
- 12.1. Recent Developments & Impact Analysis by Key Market Participants
- 12.2. Company Categorization
- 12.3. Company Heat Map/ Positioning Analysis
- 12.4. Strategy Mapping
- 12.5. Company Profiles
- 12.5.1. Amway Corp.
- 12.5.1.1. Company Overview
- 12.5.1.2. Financial Performance
- 12.5.1.3. Product Benchmarking
- 12.5.1.4. Strategic Initiatives
- 12.5.2. Glanbia PLC
- 12.5.2.1. Company Overview
- 12.5.2.2. Financial Performance
- 12.5.2.3. Product Benchmarking
- 12.5.2.4. Strategic Initiatives
- 12.5.3. Abbott
- 12.5.3.1. Company Overview
- 12.5.3.2. Financial Performance
- 12.5.3.3. Product Benchmarking
- 12.5.3.4. Strategic Initiatives
- 12.5.4. Bayer AG
- 12.5.4.1. Company Overview
- 12.5.4.2. Financial Performance
- 12.5.4.3. Product Benchmarking
- 12.5.4.4. Strategic Initiatives
- 12.5.5. Pfizer Inc.
- 12.5.5.1. Company Overview
- 12.5.5.2. Financial Performance
- 12.5.5.3. Product Benchmarking
- 12.5.5.4. Strategic Initiatives
- 12.5.6. ADM
- 12.5.6.1. Company Overview
- 12.5.6.2. Financial Performance
- 12.5.6.3. Product Benchmarking
- 12.5.6.4. Strategic Initiatives
- 12.5.7. Nu Skin Enterprises Inc.
- 12.5.7.1. Company Overview
- 12.5.7.2. Financial Performance
- 12.5.7.3. Product Benchmarking
- 12.5.7.4. Strategic Initiatives
- 12.5.8. GlaxoSmithKline plc.
- 12.5.8.1. Company Overview
- 12.5.8.2. Financial Performance
- 12.5.8.3. Product Benchmarking
- 12.5.8.4. Strategic Initiatives
- 12.5.9. Bionova
- 12.5.9.1. Company Overview
- 12.5.9.2. Financial Performance
- 12.5.9.3. Product Benchmarking
- 12.5.9.4. Strategic Initiatives
- 12.5.10. Arkopharma
- 12.5.10.1. Company Overview
- 12.5.10.2. Financial Performance
- 12.5.10.3. Product Benchmarking
- 12.5.10.4. Strategic Initiatives
- 12.5.11. Herbalife International of America, Inc.
- 12.5.11.1. Company Overview
- 12.5.11.2. Financial Performance
- 12.5.11.3. Product Benchmarking
- 12.5.11.4. Strategic Initiatives
- 12.5.12. Nature's Sunshine Products, Inc.
- 12.5.12.1. Company Overview
- 12.5.12.2. Financial Performance
- 12.5.12.3. Product Benchmarking
- 12.5.12.4. Strategic Initiatives